Enhanced Green Fluorescent Protein, EGFP (200 - 208)
% Peak Area By HPLC ≥ 95%
This peptide is H2-Kd-restricted enhanced green fluorescent protein (EGFP)-derived peptide (200-208) and represents a CD8 T cell epitope. Immunization with this peptide stimulates IFNg production, thus making this peptide a model tumor antigen for the experimental development of antigen-specific vaccines against cancer.
Wysocki, P. et al. Clin Cancer Res12, 4095 (2006); Sharma, S. et al. J Immunol177, 8348 (2006); Wingender, G. et al. Eur J Immunol36, 12 (2006); Gambotto, A. et al. Gene Ther7, 2036 (2000).
Sequence (One-Letter Code)
Sequence (Three-Letter Code)
H - His - Tyr - Leu - Ser - Thr - Gln - Ser - Ala - Leu - OH